Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
4842
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P12651 (Created: 1989-10-01 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
SPIKE_IBVM
Protein Name
Spike glycoprotein
Gene
S
Organism Scientific
Avian infectious bronchitis virus (strain M41)
Organism Common
IBV
Lineage
Viruses
ssRNA positive-strand viruses, no DNA stage
Nidovirales
Coronaviridae
Coronavirus
Coronavirus group 3
Protein Length [aa]
1162
Protein Mass [Da]
128078
Features
Type
Description
Status
Start
End
signal peptide
potential
1
18
chain
Spike glycoprotein
19
1162
chain
Spike protein S1
potential
19
537
chain
Spike protein S2
potential
538
1162
transmembrane region
potential
1096
1116
topological domain
Extracellular
potential
19
1095
topological domain
Cytoplasmic
potential
1117
1162
glycosylation site
N-linked (GlcNAc...)
potential
51
51
glycosylation site
N-linked (GlcNAc...)
potential
77
77
glycosylation site
N-linked (GlcNAc...)
potential
103
103
glycosylation site
N-linked (GlcNAc...)
potential
144
144
glycosylation site
N-linked (GlcNAc...)
potential
163
163
glycosylation site
N-linked (GlcNAc...)
potential
178
178
glycosylation site
N-linked (GlcNAc...)
potential
212
212
glycosylation site
N-linked (GlcNAc...)
potential
237
237
glycosylation site
N-linked (GlcNAc...)
potential
247
247
glycosylation site
N-linked (GlcNAc...)
potential
264
264
glycosylation site
N-linked (GlcNAc...)
potential
271
271
glycosylation site
N-linked (GlcNAc...)
potential
276
276
glycosylation site
N-linked (GlcNAc...)
potential
306
306
glycosylation site
N-linked (GlcNAc...)
potential
425
425
glycosylation site
N-linked (GlcNAc...)
potential
447
447
glycosylation site
N-linked (GlcNAc...)
potential
513
513
glycosylation site
N-linked (GlcNAc...)
potential
530
530
glycosylation site
N-linked (GlcNAc...)
potential
579
579
glycosylation site
N-linked (GlcNAc...)
potential
591
591
glycosylation site
N-linked (GlcNAc...)
potential
669
669
glycosylation site
N-linked (GlcNAc...)
potential
676
676
glycosylation site
N-linked (GlcNAc...)
potential
714
714
glycosylation site
N-linked (GlcNAc...)
potential
947
947
glycosylation site
N-linked (GlcNAc...)
potential
960
960
glycosylation site
N-linked (GlcNAc...)
potential
979
979
glycosylation site
N-linked (GlcNAc...)
potential
1014
1014
glycosylation site
N-linked (GlcNAc...)
potential
1038
1038
glycosylation site
N-linked (GlcNAc...)
potential
1051
1051
glycosylation site
N-linked (GlcNAc...)
potential
1074
1074
sequence variant
0
0
sequence variant
0
0
sequence variant
0
0
sequence variant
0
0
sequence variant
0
0
site
Cleavage; by host
potential
537
538
compositionally biased region
Cys-rich
1120
1137
short sequence motif
Di-lysine motif
by similarity
1159
1162
coiled-coil region
potential
822
866
coiled-coil region
potential
1055
1083
SP Length
18
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MLVTPLLLVTLLCVLCSA
Sequence
MLVTPLLLVTLLCVLCSA
ALYDSSSYVYYYQSAFRPPNGWHLHGGAYAVV
N
ISSESNNAGSSPGCIVGTIHGGRVV
N
ASSIAMTAPSSGMAWSSSQFCTA
HC
N
FSDTTVFVTHCYKYDGCPITGMLQKNFLRVSAMKNGQLFY
N
LTVSVA
KYPTFKSFQCVN
N
LTSVYLNGDLVYTS
N
ETTDVTSAGVYFKAGGPITYKV
MRKVKALAYFV
N
GTAQDVILCDGSPRGLLACQYNTG
N
FSDGFYPFI
N
SSL
VKQKFIVYRENSV
N
TTFTLH
N
FTFH
N
ETGANPNPSGVQNILTYQTQTAQS
GYYNF
N
FSFLSSFVYKESNFMYGSYHPSCNFRLETINNGLWFNSLSVSIA
YGPLQGGCKQSVFSGRATCCYAYSYGGPSLCKGVYSGELDLNFECGLLVY
VTKSGGSRIQTATEPPVITRHNYN
N
ITLNTCVDYNIYGRTGQGFIT
N
VTD
SAVSYNYLADAGLAILDTSGSIDIFVVQGEYGLTYYKVNPCEDVNQQFVV
SGGKLVGILTSR
N
ETGSQLLENQFYIKIT
N
GTRRFR
RS
ITENVANCPYVS
YGKFCIKPDGSIATIVPKQLEQFVAPLL
N
VTENVLIPNSF
N
LTVTDEYIQ
TRMDKVQINCLQYVCGNSLDCRDLFQQYGPVCDNILSVVNSIGQKEDMEL
LNFYSSTKPAGFNTPFLS
N
VSTGEF
N
ISLLLTTPSSPRRRSFIEDLLFTS
VESVGLPTDDAYK
N
CTAGPLGFLKDLACAREYNGLLVLPPIITAEMQTLY
TSSLVASMAFGGITAAGAIPFATQLQARINHLGITQSLLLKNQEKIAASF
NKAIGRMQEGFRSTSLALQQI
QDVVNKQSAILTETMASLNKNFGAISSVI
QEIYQQLDAIQANAQV
DRLITGRLSSLSVLASAKQAEHIRVSQQRELATQ
KINECVKSQSIRYSFCGNGRHVLTIPQNAPNGIVFIHFSYTPDSFV
N
VTA
IVGFCVKPA
N
ASQYAIVPANGRGIFIQV
N
GSYYITARDMYMPRAITAGDI
VTLTSCQANYVSV
N
KTVITTFVDNDDFDFNDELSKWW
N
DTKHELPDFDKF
N
YTV
PILDIDSEIDRIQGVIQGLNDSLIDLEKL
SILKTYIKWPWY
VWLAI
AFATIIFILILGWVFF
MTG
CCGCCCGCFGIMPLMSKC
GKKSSYYTTFDND
VVTEQNRP
KKSV
Original
MLVTPLLLVTLLCVLCSAALYDSSSYVYYYQSAFRPPNGWHLHGGAYAVV
NISSESNNAGSSPGCIVGTIHGGRVVNASSIAMTAPSSGMAWSSSQFCTA
HCNFSDTTVFVTHCYKYDGCPITGMLQKNFLRVSAMKNGQLFYNLTVSVA
KYPTFKSFQCVNNLTSVYLNGDLVYTSNETTDVTSAGVYFKAGGPITYKV
MRKVKALAYFVNGTAQDVILCDGSPRGLLACQYNTGNFSDGFYPFINSSL
VKQKFIVYRENSVNTTFTLHNFTFHNETGANPNPSGVQNILTYQTQTAQS
GYYNFNFSFLSSFVYKESNFMYGSYHPSCNFRLETINNGLWFNSLSVSIA
YGPLQGGCKQSVFSGRATCCYAYSYGGPSLCKGVYSGELDLNFECGLLVY
VTKSGGSRIQTATEPPVITRHNYNNITLNTCVDYNIYGRTGQGFITNVTD
SAVSYNYLADAGLAILDTSGSIDIFVVQGEYGLTYYKVNPCEDVNQQFVV
SGGKLVGILTSRNETGSQLLENQFYIKITNGTRRFRRSITENVANCPYVS
YGKFCIKPDGSIATIVPKQLEQFVAPLLNVTENVLIPNSFNLTVTDEYIQ
TRMDKVQINCLQYVCGNSLDCRDLFQQYGPVCDNILSVVNSIGQKEDMEL
LNFYSSTKPAGFNTPFLSNVSTGEFNISLLLTTPSSPRRRSFIEDLLFTS
VESVGLPTDDAYKNCTAGPLGFLKDLACAREYNGLLVLPPIITAEMQTLY
TSSLVASMAFGGITAAGAIPFATQLQARINHLGITQSLLLKNQEKIAASF
NKAIGRMQEGFRSTSLALQQIQDVVNKQSAILTETMASLNKNFGAISSVI
QEIYQQLDAIQANAQVDRLITGRLSSLSVLASAKQAEHIRVSQQRELATQ
KINECVKSQSIRYSFCGNGRHVLTIPQNAPNGIVFIHFSYTPDSFVNVTA
IVGFCVKPANASQYAIVPANGRGIFIQVNGSYYITARDMYMPRAITAGDI
VTLTSCQANYVSVNKTVITTFVDNDDFDFNDELSKWWNDTKHELPDFDKF
NYTVPILDIDSEIDRIQGVIQGLNDSLIDLEKLSILKTYIKWPWYVWLAI
AFATIIFILILGWVFFMTGCCGCCCGCFGIMPLMSKCGKKSSYYTTFDND
VVTEQNRPKKSV
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11